|
AU2005222541A1
|
|
Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
|
|
AU2004202678A1
|
|
2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
|
|
US2004009993A1
|
|
Pyridopyrimidinones derivatives as telomerase inhibitors
|
|
GB0131034D0
|
|
Benzocyclodecane derivatives with antitumor activity
|
|
US2004010027A1
|
|
Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them
|
|
GB0122257D0
|
|
Simplified sarcodictyin derivatives
|
|
CN1466458A
|
|
Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration
|
|
AU9184301A
|
|
Glutathione conjugates with distamycin derivatives having antitumoral activity
|
|
GB0119578D0
|
|
Fluoro linkers
|
|
TWI327569B
|
|
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US6750215B2
|
|
Substituted benzoxazines as integrin antagonists
|
|
US6794385B2
|
|
Benzoxazine derivatives useful as integrin receptor antagonists
|
|
US2003073692A1
|
|
Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
|
AU8396401A
|
|
Composition for combined use of aromatase inhibitors
|
|
GB0117403D0
|
|
Solvent-free crystalline anthracycline derivatives
|
|
GB0116835D0
|
|
Interaction inhibitors of TCF-4 with ›-catenin
|
|
GB0114654D0
|
|
Anti-tumor compound
|
|
GB0111071D0
|
|
Disubstituted 1, 7-guanines
|
|
GB0111072D0
|
|
Disubstituted 7, 9-guaninium halides
|
|
EP1282401A2
|
|
Stabilized steroidal suspension
|
